×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [3]
Authors
CHEN XIN [3]
Document Type
Journal article [4]
Date Issued
2023 [1]
2021 [1]
2018 [1]
2014 [1]
Language
英語English [4]
Source Publication
Cytokine [1]
FRONTIERS IN IMM... [1]
Frontiers in Imm... [1]
IMMUNOTARGETS AN... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
WOS Cited Times Ascending
WOS Cited Times Descending
TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments
Journal article
Ping Liao, Mengmeng Jiang, Md Sahidul Islam, Yiru Wang, XIN CHEN*. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments[J]. Frontiers in Immunology, 2023, 14, 1097090.
Authors:
Ping Liao
;
Mengmeng Jiang
;
Md Sahidul Islam
;
Yiru Wang
;
XIN CHEN*
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
5.7
/
6.8
|
Submit date:2023/08/31
Tnfr2
Immune Checkpoint Inhibitors
Tumor Microenvironment
Cd4 + Foxp3 + Regulatory t Cells
Exhausted Cd8 t Cells
Biomarker
TNFR2: Role in Cancer Immunology and Immunotherapy
Journal article
Yang, Y., Islam, M.S., Hu, Y. J., Chen, X.*. TNFR2: Role in Cancer Immunology and Immunotherapy[J]. IMMUNOTARGETS AND THERAPY, 2021, 103-122.
Authors:
Yang, Y.
;
Islam, M.S.
;
Hu, Y. J.
;
Chen, X.*
Favorite
|
IF:
6.2
/
8.1
|
Submit date:2022/08/30
Tnf
Tnfr2
Cancer Immunology And Immunotherapy
Cd4(+)Foxp3(+) Regulatory t Cells
Tumor Immune Microenvironment
The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells
Journal article
He, Tianzhen, Liu, Shuoyang, Chen, Shaokui, Ye, Jingyi, Wu, Xueqiang, Bian, Zhaoxiang, Chen, Xin. The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9.
Authors:
He, Tianzhen
;
Liu, Shuoyang
;
Chen, Shaokui
;
Ye, Jingyi
;
Wu, Xueqiang
; et al.
Favorite
|
TC[WOS]:
34
TC[Scopus]:
34
IF:
5.7
/
6.8
|
Submit date:2018/10/30
Tumor Necrosis Factor
Tnf Receptor Type Ii
P38 Mapk
Cd4(+)Foxp3(+) Regulatory t Cells
Proliferation
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
Journal article
Zhou, Q., Hu, Y., Howard, O., Oppenheim, J., Chen, X.. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.[J]. Cytokine, 2014, 56-64.
Authors:
Zhou, Q.
;
Hu, Y.
;
Howard, O.
;
Oppenheim, J.
;
Chen, X.
Favorite
|
IF:
3.7
/
3.5
|
Submit date:2022/08/30
FoxP3
IL-2
KI
KO
Regulatory T cell
TNF
TNFR2
TNFR2 Fc fusion protein
TNFR2-Fc
Teffs
Th17
Tregs
effector T cells
forkhead box P3
knock in
knock out
nCD4
naïve CD4 cells
regulatory T cells
tumor necrosis factor receptor type II